Trastuzumab Deruxtecan in Non-Small-Cell Lung Cancer. Reply

Bob T. Li, Egbert F. Smit, Pasi A. Jänne

Research output: Contribution to journal › Letter › Academic › peer-review

Original language	English
Pages (from-to)	1770-1771
Number of pages	2
Journal	The New England journal of medicine
Volume	386
Issue number	18
DOIs	https://doi.org/10.1056/NEJMc2202305
Publication status	Published - 5 May 2022

Access to Document

@article{b6cb23911ce84faea16ad7355c70b95f,

title = "Trastuzumab Deruxtecan in Non-Small-Cell Lung Cancer. Reply",

author = "Li, {Bob T.} and Smit, {Egbert F.} and J{\"a}nne, {Pasi A.}",

year = "2022",

month = may,

day = "5",

doi = "10.1056/NEJMc2202305",

language = "English",

volume = "386",

pages = "1770--1771",

journal = "New England Journal of Medicine",

issn = "0028-4793",

publisher = "Massachussetts Medical Society",

number = "18",

}

TY - JOUR

T1 - Trastuzumab Deruxtecan in Non-Small-Cell Lung Cancer. Reply

AU - Li, Bob T.

AU - Smit, Egbert F.

AU - Jänne, Pasi A.

PY - 2022/5/5

Y1 - 2022/5/5

UR - http://www.scopus.com/inward/record.url?scp=85129360015&partnerID=8YFLogxK

U2 - 10.1056/NEJMc2202305

DO - 10.1056/NEJMc2202305

M3 - Letter

C2 - 35507496

SN - 0028-4793

VL - 386

SP - 1770

EP - 1771

JO - New England Journal of Medicine

JF - New England Journal of Medicine

IS - 18

ER -